Biocompatible gold nanoparticles designed to absorb light at wavelengths of high tissue
transparency have been of particular interest for biomedical applications. The ability of such …

Cisplatin-based chemotherapy is the standard of care for patients with muscle-invasive
urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based …

While patient age and gender are important factors in the clinical decision‐making for
treating urothelial carcinoma of the bladder (UCB), there are no evidence‐based …

Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-altering.
We initiated a phase 2 study in which patients with MIBC received four cycles of …

Cancers infiltrated with T-cells are associated with a higher likelihood of response to PD-1/PD-L1
blockade. Counterintuitively, a correlation between epithelial–mesenchymal transition (…

… Author links open overlay panel John P. Sfakianos a b , Eugene K. Cha a , Gopa Iyer c d , …
Sfakianos was a research fellow in urologic oncology supported by NIH T32-CA82088. …

Purpose Given that randomized trials exploring adjuvant chemotherapy for bladder cancer
have been underpowered and/or terminated prematurely, yielding inconsistent results and …

Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1)-blockade
immunotherapies have limited efficacy in the treatment of bladder cancer. Here, we show that …

Purpose We determined whether restaging resection before initiating induction intravesical
bacillus Calmette-Guérin improves the recurrence-free rate in patients with high risk …

Purpose: To investigate genomic differences between urothelial carcinomas of the upper
tract (UTUC) and bladder (UCB), with a focus on defining the clonal relatedness of temporally …